ClinicalTrials.Veeva

Menu

Effect of Sulthiame on EEG in Childhood Epilepsy Syndromes (SURF)

U

University Hospital, Angers

Status

Enrolling

Conditions

Importance of Interictal Epileptiform Activity on Sleep EEG
Epilepsy in Children

Treatments

Drug: Sulthiame

Study type

Observational

Funder types

Other

Identifiers

NCT05885646
49RC23_0073

Details and patient eligibility

About

The effect of sulthiame on EEG has been studied in epilepsy syndromes of childhood with sleep activation by comparing sleep EEG obtained at baseline and after 4 weeks of treatment. The aim of the study is to know if an effect is still identifiable after 2 weeks of treatment by performing sleep EEG recordings after 2 and 4 weeks of treatment, respectively.

Enrollment

15 estimated patients

Sex

All

Ages

6 to 15 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of epilepsy syndromes of childhood with sleep activation
  • Failure of at least two anti-epileptic drugs (AED)
  • Sleep EEG performed in the last 7 days before inclusion and showing interictal epileptiform discharges (baseline EEG)

Exclusion criteria

  • Previous trial with sulthiame
  • More than 2 AED at inclusion
  • Use of corticosteroids at inclusion
  • Change in the anti-epileptic treatment in the 7 days before baseline EEG

Trial contacts and locations

3

Loading...

Central trial contact

Patrick Van Bogaert, Professor; Elsa Berardi

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems